The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis
Open accessAbstract
Insulin-like growth factor-binding protein-3 (IGFBP-3) regulates IGF bioactivity and also independently modulates cell growth and survival. By using a yeast two-hybrid screen to identify IGFBP-3-interacting proteins, we cloned humanin (HN) as an IGFBP-3-binding partner. HN is a 24-aa peptide that has been shown to specifically inhibit neuronal cell death induced by familial Alzheimer's disease mutant genes and amyloid-β (Aβ). The physical interaction of HN with IGFBP-3 was determined to be of high affinity and specificity and was confirmed by yeast mating, displaceable pull-down experiments with (His)-6-tagged HN, and ligand blot experiments. Coimmunoprecipitation of IGFBP-3 and HN from mouse testes confirmed the interaction in vivo. In cross-linking experiments, HN bound IGFBP-3 but did not compete with IGF-I–IGFBP-3 binding; competitive ligand dot blot experiments revealed the 18-aa heparin-binding domain of IGFBP-3 as the binding site for HN. Alanine scanning determined that F6A-HN mutant does not bind IGFBP-3. HN but not F6A-HN inhibited IGFBP-3-induced apoptosis in human glioblastoma-A172. In contrast, HN did not suppress IGFBP-3 response in SH-SY5Y neuroblastoma and mouse cortical primary neurons. In primary neurons, IGFBP-3 markedly potentiated HN rescue ability from Aβ 1–43 toxicity. In summary, we have identified an interaction between the survival peptide HN and IGFBP-3 that is pleiotrophic in nature and is capable of both synergistic and antagonistic interaction. This interaction may prove to be important in neurological disease processes and could provide important targets for drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
Self-citationHashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101133498 · Cited by 623
Self-citationHumanin peptide suppresses apoptosis by interfering with Bax activation
Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A. C., & Reed, J. C. (2003) · Nature · doi:10.1038/nature01627 · Cited by 617
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Self-citationBredesen, D. E. (1995) · Annals of Neurology · doi:10.1002/ana.410380604 · Cited by 484
Serum insulin-like growth factor I regulates brain amyloid-β levels
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002) · Nature Medicine · doi:10.1038/nm793 · Cited by 448
Serum insulin-like growth factor I regulates brain amyloid-β levels
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002) · Nature Medicine · doi:10.1038/nm1202-793 · Cited by 440
Liu, B., Lee, H.-Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L., Kurie, J. M., & Cohen, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002547200 · Cited by 326
Self-citationControl of cell survival by IGF signaling pathways
Vincent, A. M., & Feldman, E. L. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00017-5 · Cited by 289
Tajima, H., Niikura, T., Hashimoto, Y., Ito, Y., Kita, Y. A., Terashita, K., Yamazaki, K., Koto, A., Aiso, S., & Nishimoto, I. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00199-4 · Cited by 150
Self-citationTransferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein
WEINZIMER, S. A., Gibson, T. B., Collett‐Solberg, P. F., Khare, A., Liu, B.-R., & Cohen, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7380 · Cited by 125
Self-citationNiikura, T., Hashimoto, Y., Tajima, H., Ishizaka, M., Yamagishi, Y., Kawasumi, M., Nawa, M., Terashita, K., Aiso, S., & Nishimoto, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02553.x · Cited by 115
Self-citationYamagishi, Y., Hashimoto, Y., Niikura, T., & Nishimoto, I. (2003) · Peptides · doi:10.1016/s0196-9781(03)00106-2 · Cited by 105
Self-citationInvolvement of c‐Jun N‐terminal kinase in amyloid precursor protein‐mediated neuronal cell death
Hashimoto, Y., Tsuji, O., Niikura, T., Yamagishi, Y., Ishizaka, M., Kawasumi, M., Chiba, T., Kanekura, K., Yamada, M., Tsukamoto, E., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01585.x · Cited by 102
Self-citationNiikura, T., Hashimoto, Y., Okamoto, T., Abe, Y., Yasukawa, T., Kawasumi, M., Hiraki, T., Kita, Y. A., Terashita, K., Kouyama, K., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01902.2001 · Cited by 84
Self-citationDeath and survival of neuronal cells exposed to Alzheimer's insults
Niikura, T., Hashimoto, Y., Tajima, H., & Nishimoto, I. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10354 · Cited by 80
Self-citationHumanin inhibits cell death of serum-deprived PC12h cells
Kariya, S., Takahashi, N., Ooba, N., Kawahara, M., Nakayama, H., & Ueno, S. (2002) · Neuroreport · doi:10.1097/00001756-200205070-00034 · Cited by 77
Terashita, K., Hashimoto, Y., Niikura, T., Tajima, H., Yamagishi, Y., Ishizaka, M., Kawasumi, M., Chiba, T., Kanekura, K., Yamada, M., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01797.x · Cited by 75
Self-citationHumanin rescues human cerebrovascular smooth muscle cells from Aβ‐induced toxicity
Jung, S. S., & Van Nostrand, W. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01524.x · Cited by 67
Beilharz, E. J., Klempt, N. D., Klempt, M., Sirimanne, E. S., Dragunow, M., & Gluckman, P. D. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90191-q · Cited by 64
Shen, L., Dean, N. M., & Glazer, R. I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12039-1 · Cited by 64
A novel rat gene encoding a Humanin‐like peptide endowed with broad neuroprotective activity
Caricasole, A., Bruno, V., Cappuccio, I., Melchiorri, D., Copani, A., & Nicoletti, F. (2002) · The FASEB Journal · doi:10.1096/fj.02-0018fje · Cited by 60
Rensink, A., Gellekink, H., Otte-Höller, I., ten Donkelaar, H. T., de Waal, R., Verbeek, M., & Kremer, B. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0585-x · Cited by 51
Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
Campbell, P. G., Durham, S. K., Suwanichkul, A., Hayes, J. D., & Powell, D. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.2.e321 · Cited by 49
Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Conway, K., Baxter, E., Felsenstein, K., & Reitz, A. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391649 · Cited by 40
Roschier, M., Kuusisto, E., Suuronen, T., Korhonen, P., Kyrylenko, S., & Salminen, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00002.x · Cited by 28
Cited by
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.-J., Mehta, H., Hevener, A. L., de Cabo, R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.009 · Cited by 715
Self-citationThe Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Russo, V. C., Gluckman, P. D., Feldman, E. L., & Werther, G. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0024 · Cited by 492
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
Cobb, L. J., Lee, C., Xiao, J., Yen, K., Wong, R. G., Nakamura, H. K., Mehta, H. H., Gao, Q., Ashur, C., Huffman, D. M., et al. (2016) · Aging · doi:10.18632/aging.100943 · Cited by 286
Self-citation
Metadata
- Authors
- Ikonen, M., Liu, B., Hashimoto, Y., Ma, L., Lee, K.-W., Niikura, T., Nishimoto, I., & Cohen, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-10-15
- Volume
- 100
- Issue
- 22
- Pages
- 13042-13047
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060217146
- Cited by
- 279
- References
- 27
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.